Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. ?
1
High Management Efficiency with a high ROE of 11.75%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 9.23
3
High Debt company with Weak Long Term Fundamental Strength
4
Flat results in Dec 15
5
With ROE of 7.53%, it has a Fair valuation with a 0.10 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 1.58%, its profits have fallen by -28.3%
6
Underperformed the market in the last 1 year
- The stock has generated a return of 1.58% in the last 1 year, much lower than market (Hang Seng Hong Kong) returns of 27.36%
How much should you hold?
- Overall Portfolio exposure to Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
1.58%
-1.03
18.94%
Hang Seng Hong Kong
27.36%
1.06
25.88%
Quality key factors
Factor
Value
Sales Growth (5y)
4.06%
EBIT Growth (5y)
-0.25%
EBIT to Interest (avg)
9.23
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.57
Tax Ratio
16.19%
Dividend Payout Ratio
46.45%
Pledged Shares
0
Institutional Holding
0.14%
ROCE (avg)
15.88%
ROE (avg)
11.75%
Valuation Key Factors 
Factor
Value
P/E Ratio
1
Industry P/E
Price to Book Value
0.10
EV to EBIT
0.86
EV to EBITDA
0.65
EV to Capital Employed
0.07
EV to Sales
0.03
PEG Ratio
NA
Dividend Yield
4.77%
ROCE (Latest)
7.89%
ROE (Latest)
7.53%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Raw Material Cost
Fallen by -19.1% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales






